Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)
Go back to Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)| (NASDAQ: CRSP) | Delayed: 56.22 -0.6 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.82 | 52 Week High | $18.88 | |||
| Open | $57.13 | 52 Week Low | $13.75 | |||
| Day High | $58.96 | P/E | N/A | |||
| Day Low | $55.59 | EPS | $0.00 | |||
| Volume | 448,117 | |||||
